RPG Life Sciences Limited (RPGLIFE) - Total Liabilities
Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) has total liabilities worth Rs1.88 Billion INR (≈ $20.31 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore RPGLIFE net assets growth trend to track the company's year-over-year net asset growth rate.
RPG Life Sciences Limited - Total Liabilities Trend (2005–2026)
This chart illustrates how RPG Life Sciences Limited's total liabilities have evolved over time, based on quarterly financial data. See RPG Life Sciences Limited (RPGLIFE) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
RPG Life Sciences Limited Competitors by Total Liabilities
The table below lists competitors of RPG Life Sciences Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DukSan Neolux Co.Ltd
KQ:213420
|
Korea | ₩236.09 Billion |
|
Grid Dynamics Holdings Inc
NASDAQ:GDYN
|
USA | $74.90 Million |
|
Aprogen KIC Inc
KO:007460
|
Korea | ₩323.51 Billion |
|
Ningbo Daye Garden Machinery Co Ltd
SHE:300879
|
China | CN¥3.52 Billion |
|
Kambi Group PLC
ST:KAMBI
|
Sweden | Skr37.87 Million |
|
Zhejiang Yilida Ventilator Co Ltd
SHE:002686
|
China | CN¥1.28 Billion |
|
AGI Greenpac Limited
NSE:AGI
|
India | Rs11.47 Billion |
|
Lycopodium Ltd
AU:LYL
|
Australia | AU$105.85 Million |
Liability Composition Analysis (2005–2026)
This chart breaks down RPG Life Sciences Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see RPGLIFE market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how RPG Life Sciences Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for RPG Life Sciences Limited (2005–2026)
The table below shows the annual total liabilities of RPG Life Sciences Limited from 2005 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs1.88 Billion ≈ $20.31 Million |
+47.56% |
| 2025-03-31 | Rs1.27 Billion ≈ $13.76 Million |
-7.78% |
| 2024-03-31 | Rs1.38 Billion ≈ $14.93 Million |
+23.51% |
| 2023-03-31 | Rs1.12 Billion ≈ $12.09 Million |
+25.79% |
| 2022-03-31 | Rs888.40 Million ≈ $9.61 Million |
+2.19% |
| 2021-03-31 | Rs869.40 Million ≈ $9.40 Million |
-3.57% |
| 2020-03-31 | Rs901.60 Million ≈ $9.75 Million |
-0.64% |
| 2019-03-31 | Rs907.40 Million ≈ $9.81 Million |
-33.53% |
| 2018-03-31 | Rs1.37 Billion ≈ $14.76 Million |
+48.09% |
| 2017-03-31 | Rs921.90 Million ≈ $9.97 Million |
+28.69% |
| 2016-03-31 | Rs716.40 Million ≈ $7.75 Million |
-0.15% |
| 2015-03-31 | Rs717.50 Million ≈ $7.76 Million |
+2.05% |
| 2014-03-31 | Rs703.10 Million ≈ $7.60 Million |
-45.72% |
| 2013-03-31 | Rs1.30 Billion ≈ $14.01 Million |
+19.10% |
| 2012-03-31 | Rs1.09 Billion ≈ $11.76 Million |
-6.29% |
| 2011-03-31 | Rs1.16 Billion ≈ $12.55 Million |
+12.75% |
| 2010-03-31 | Rs1.03 Billion ≈ $11.13 Million |
-8.91% |
| 2009-03-31 | Rs1.13 Billion ≈ $12.22 Million |
-10.46% |
| 2008-03-31 | Rs1.26 Billion ≈ $13.65 Million |
-3.84% |
| 2007-03-31 | Rs1.31 Billion ≈ $14.19 Million |
-14.03% |
| 2006-03-31 | Rs1.53 Billion ≈ $16.51 Million |
-30.66% |
| 2005-03-31 | Rs2.20 Billion ≈ $23.81 Million |
-- |
About RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more